ClinicalTrials.gov studies

All records

Every Clinical trial record published by Orca1, 1000 per page. Each page lists the record id and its name; open a record for key facts, related records and what Orca1 adds.

1. NCT00000102Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
2. NCT00000104Does Lead Burden Alter Neuropsychological Development?
3. NCT00000105Vaccination With Tetanus and KLH to Assess Immune Responses.
4. NCT0000010641.8 Degree Centigrade Whole Body Hyperthermia for the Treatment of Rheumatoid Diseases
5. NCT00000107Body Water Content in Cyanotic Congenital Heart Disease
6. NCT00000108Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women
7. NCT00000110Influence of Diet and Endurance Running on Intramuscular Lipids Measured at 4.1 TESLA
8. NCT00000111Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
9. NCT00000112Prevalence of Carbohydrate Intolerance in Lean and Obese Children
10. NCT00000113Correction of Myopia Evaluation Trial (COMET)
11. NCT00000114Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
12. NCT00000115Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
13. NCT00000116Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A
14. NCT00000117Intravenous Immunoglobulin Therapy in Optic Neuritis
15. NCT00000118Ganciclovir Implant Study for Cytomegalovirus Retinitis
16. NCT00000119Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
17. NCT00000120Clinical Trial of Eye Prophylaxis in the Newborn
18. NCT00000121The Prism Adaptation Study (PAS)
19. NCT00000122Fluorouracil Filtering Surgery Study (FFSS)
20. NCT00000123The Berkeley Orthokeratology Study
21. NCT00000124Collaborative Ocular Melanoma Study (COMS)
22. NCT00000125Ocular Hypertension Treatment Study (OHTS)
23. NCT00000126Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
24. NCT00000127Ischemic Optic Neuropathy Decompression Trial (IONDT)
25. NCT00000128A Trial of Bifocals in Myopic Children With Esophoria
26. NCT00000129Prospective Evaluation of Radial Keratotomy (PERK) Study
27. NCT00000130Endophthalmitis Vitrectomy Study (EVS)
28. NCT00000131Central Vein Occlusion Study (CVOS)
29. NCT00000132Early Manifest Glaucoma Trial (EMGT)
30. NCT00000133Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for…
31. NCT00000134Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment…
32. NCT00000135Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis…
33. NCT00000136Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis…
34. NCT00000137Collaborative Corneal Transplantation Studies (CCTS)
35. NCT00000138Herpetic Eye Disease Study (HEDS) I
36. NCT00000139Herpetic Eye Disease Study (HEDS) II
37. NCT00000140The Silicone Study
38. NCT00000142Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial…
39. NCT00000143Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial…
40. NCT00000144Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)
41. NCT00000145Age-Related Eye Disease Study (AREDS)
42. NCT00000146Optic Neuritis Treatment Trial (ONTT)
43. NCT00000147Longitudinal Optic Neuritis Study (LONS)
44. NCT00000148Advanced Glaucoma Intervention Study (AGIS)
45. NCT00000149Collaborative Initial Glaucoma Treatment Study (CIGTS)
46. NCT00000150Submacular Surgery Trials (SST)
47. NCT00000151Early Treatment Diabetic Retinopathy Study (ETDRS)
48. NCT00000152Randomized Trial of Beta-Carotene and Macular Degeneration
49. NCT00000153Krypton-Argon Regression of Neovascularization Study (KARNS)
50. NCT00000154Diabetic Retinopathy Vitrectomy Study (DRVS)
51. NCT00000155The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study
52. NCT00000156The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
53. NCT00000157Randomized Trial of Aspirin and Cataracts in U.S. Physicians
54. NCT00000158Macular Photocoagulation Study (MPS)
55. NCT00000159Sorbinil Retinopathy Trial (SRT)
56. NCT00000160Diabetic Retinopathy Study (DRS)
57. NCT00000161Randomized Trials of Vitamin Supplements and Eye Disease
58. NCT00000162Branch Vein Occlusion Study
59. NCT00000163Congenital Esotropia Observational Study (CEOS)
60. NCT00000167Complications of Age-Related Macular Degeneration Prevention Trial
61. NCT00000168Longitudinal Study of Ocular Complications of AIDS (LSOCA)
62. NCT00000169The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
63. NCT00000170Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia
64. NCT00000171Study of Melatonin: Sleep Problems in Alzheimer's Disease
65. NCT00000172Evaluation of Galantamine in the Treatment of Alzheimer's Disease
66. NCT00000173Memory Impairment Study (Mild Cognitive Impairment Study)
67. NCT00000174Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
68. NCT00000175The Effects of Sex Hormones on Cognition and Mood in Older Adults
69. NCT00000176Alzheimer's Disease Prevention Trial
70. NCT00000177Estrogen Hormone Protocol
71. NCT00000178Multicenter Trial of Prednisone in Alzheimer's Disease
72. NCT00000179Agitation in Alzheimer's Disease
73. NCT00000180AIT-082 Phase 1B Study
74. NCT00000187Ritanserin in Treatment of Cocaine Dependence - 1
75. NCT00000188Selegiline in Treatment of Cocaine Dependence - 2
76. NCT00000189Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
77. NCT00000190Cocaine in Parotid Saliva, Blood and Urine - 4
78. NCT00000191Carbamazepine Treatment for Cocaine Dependence - 5
79. NCT00000192Neurobiology of Opioid Dependence: 1 - 1
80. NCT00000193Neurobiology of Opioid Dependence: 2 - 2
81. NCT00000194Neurobiology of Opioid Dependence: 3 - 3
82. NCT00000195Neurobiology of Opioid Dependence: 4 - 4
83. NCT00000196Neurobiology of Opioid Dependence: 5 - 5
84. NCT00000197Propranolol for Treatment of Cocaine Addiction - 2
85. NCT00000198Piracetam for Treatment of Cocaine Addiction - 3
86. NCT00000199Piracetam for Treatment of Cocaine Addiction, Phase II - 4
87. NCT00000200Cocaine Effects in Humans: Physiology and Behavior - 1
88. NCT00000201Pharmacological Modulation of Cocaine Effects - 1
89. NCT00000202Buprenorphine Maintenance for Opioid Addicts - 1
90. NCT00000203Buprenorphine Maintenance for Opioid Addicts - 2
91. NCT00000204Buprenorphine Maintenance for Opioid Addicts - 3
92. NCT00000205Buprenorphine Maintenance Protocol - 1
93. NCT00000206Clinical Rescue Protocol - 2
94. NCT00000207Multicenter Clinical Trial of Buprenorphine - 3
95. NCT00000208Methadone/Buprenorphine Cross-Over Study - 4
96. NCT00000209Buprenorphine Dosing Interval - 5
97. NCT00000210Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
98. NCT00000211Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
99. NCT00000212IV Cocaine Abuse: A Laboratory Model - 1
100. NCT00000213IV Cocaine Abuse: A Laboratory Model - 2
101. NCT00000214IV Cocaine Abuse: A Laboratory Model - 3
102. NCT00000215IV Cocaine Abuse: A Laboratory Model - 4
103. NCT00000216Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
104. NCT00000217Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
105. NCT00000218Pharmacotherapy and Intensive Treatment - 2
106. NCT00000219Buprenorphine Dose Alteration Study - 1
107. NCT00000220Gradual Vs. Rapid Buprenorphine Detoxification - 2
108. NCT00000221Alternate-Day Buprenorphine Administration. Phase I - 3
109. NCT00000222Alternate-Day Buprenorphine Administration. Phase II - 4
110. NCT00000223Alternate-Day Buprenorphine Administration. Phase IV - 5
111. NCT00000224Alternate-Day Buprenorphine. Phase V - 6
112. NCT00000225Alternate-Day Buprenorphine Administration. Phase VI - 7
113. NCT00000226Alternate-Day Buprenorphine Administration. Phase VII - 8
114. NCT00000227Alternate-Day Buprenorphine Administration. Phase VIII - 9
115. NCT00000228Buprenorphine Detox With Two Types of Treatment. BBD I - 10
116. NCT00000229Buprenorphine Detox With Two Types of Treatment. BBD II - 11
117. NCT00000230Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
118. NCT00000231Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
119. NCT00000232Alternate Day Buprenorphine Administration, Phase IX - 14
120. NCT00000233Alternate Day Buprenorphine Administration, Phase X - 15
121. NCT00000234Alternate Day Buprenorphine Administration, Phase XI - 16
122. NCT00000235Alternate Day Buprenorphine Administration, Phase XII - 17
123. NCT00000236Buprenorphine Pharmacology Related to Addiction Treatment - 18
124. NCT00000237Buprenorphine Detoxification - BBDVI - 19
125. NCT00000238Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
126. NCT00000239Buprenorphine Pharmacology Related to Addiction Treatment - 21
127. NCT00000240Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement…
128. NCT00000241Flupenthixol Decanoate in Methamphetamine Smoking - 1
129. NCT00000242Carbamazepine Treatment of Cocaine Dependence - 1
130. NCT00000243Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are…
131. NCT00000244Effects of Dynorphin 1-13 on Heroin Addiction - 1
132. NCT00000245Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
133. NCT00000246Rapid Benzodiazepine Detoxification Using Flumazenil - 1
134. NCT00000248Dose Response Trial of Pergolide for Cocaine Dependence - 1
135. NCT00000249Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
136. NCT00000250Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
137. NCT00000251Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
138. NCT00000252Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
139. NCT00000253Effects of Nitrous Oxide: A Dose-Response Analysis - 5
140. NCT00000254Isoflurane at Subanesthetic Concentrations - 6
141. NCT00000255Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
142. NCT00000256Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
143. NCT00000257Effects of Alcohol History on Effects of Nitrous Oxide - 9
144. NCT00000258Role of Instructions in Nitrous Oxide Effects and Choice - 10
145. NCT00000259Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
146. NCT00000260Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
147. NCT00000261Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
148. NCT00000262Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
149. NCT00000263Effects of Combined Alcohol and Nitrous Oxide Intake - 15
150. NCT00000264Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
151. NCT00000265Subjective Effects of Nitrous Oxide in Dental Patients - 17
152. NCT00000266Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
153. NCT00000267Risperidone Treatment in Dually-Diagnosed Individuals - 2
154. NCT00000268Cocaine Abuse and Attention Deficit Disorder - 3
155. NCT00000269Pergolide Treatment for Substance Abusers - 4
156. NCT00000270Brain Imaging: Cocaine Effects & Medication Development - 5
157. NCT00000271New Approaches to Cocaine Abuse Medications (A) - 6
158. NCT00000273A Laboratory Model for Heroin Abuse Medications - 8
159. NCT00000274Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
160. NCT00000275Cocaine Abuse and ADHD - 10
161. NCT00000276Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
162. NCT00000277Mazindol for Cocaine Abuse - 2
163. NCT00000278Disulfiram for Cocaine-Alcohol Abuse - 3
164. NCT00000279Novel Medications for Opiate Detoxification - 4
165. NCT00000280Glutaminergic Agents for Cocaine Abuse - 5
166. NCT00000281Pharmacotherapy for Schizophrenic Drug Users - 6
167. NCT00000282Pemoline for Cocaine Abuse - 7
168. NCT00000284Role of Metabolites in Nicotine Dependence (1) - 1
169. NCT00000285Effects of Phenytoin on Cocaine Use in Humans - 2
170. NCT00000286Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
171. NCT00000287Relapse Patterns in Female Cocaine Users - 4
172. NCT00000288Role of Metabolites in Nicotine Dependence (2) - 5
173. NCT00000289Role of Metabolites in Nicotine Dependence (3) - 6
174. NCT00000290Stress Hormones and Human Cocaine Use - 7
175. NCT00000291Effects of Labetalol on Human Cocaine Use - 8
176. NCT00000292Acute Withdrawal From Smoked Cocaine - 9
177. NCT00000293Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
178. NCT00000294Effects of Carvedilol on Cocaine Use in Humans - 11
179. NCT00000295Progesterone Treatment in Female Smokers - 12
180. NCT00000296Role of Metabolites in Nicotine Dependence (4) - 13
181. NCT00000297Effects of Labetalol on Nicotine Administration in Humans - 14
182. NCT00000298Buprenorphine Combination Tablet Feasibility - 1
183. NCT00000299Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
184. NCT00000300Feasibility Study of Take-Home LAAM Medication - 3
185. NCT00000301Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
186. NCT00000302Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
187. NCT00000303Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
188. NCT00000304Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
189. NCT00000305Amphetamine Cocaine Interaction Study - 2
190. NCT00000306Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
191. NCT00000307Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
192. NCT00000308Dextroamphetamine-Cocaine Behavioral Intervention - 5
193. NCT00000309Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
194. NCT00000310Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
195. NCT00000311Combining Behavioral Treatment With Agonist Maintenance - 1
196. NCT00000312Alterations in Serotonergic Functions in Cocaine Addicts - 1
197. NCT00000313Predictive Values of Serotonergic Alterations for Outcome - 2
198. NCT00000314M-CPP and Fenfluramine in Cocaine Addicts - 3
199. NCT00000315Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
200. NCT00000316Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
201. NCT00000317Early Phase II Trials for Cocaine Medication Development - 1
202. NCT00000318Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
203. NCT00000319Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
204. NCT00000320Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
205. NCT00000321Methamphetamine Abuse Treatment in Patients With AIDS - 1
206. NCT00000322Tyrosine for Methamphetamine Dependence - 1
207. NCT00000323Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
208. NCT00000324Tryptophan and Behavior Therapy for Cocaine Abuse - 1
209. NCT00000325Psychostimulant Abuse - Novel Treatment Approaches - 1
210. NCT00000326Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
211. NCT00000327Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
212. NCT00000328Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
213. NCT00000329Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
214. NCT00000330Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
215. NCT00000331Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
216. NCT00000332High Dose Nimodipine Treatment Adjunct - 1
217. NCT00000333Evaluation of Benztropine for Cocaine Craving - 2
218. NCT00000334Comparison of Buprenorphine and Methadone - 3
219. NCT00000335Activity Monitoring Assessment of Opiate Withdrawal - 4
220. NCT00000336Selegiline in Outpatient Treatment for Cocaine Dependence - 1
221. NCT00000337Infusion Laboratory: Protocol 1 - Selegeline - 2
222. NCT00000338Infusion Laboratory: Protocol 2 (Lisuride) - 3
223. NCT00000339Infusion Laboratory: Protocol 3 (Risperidone) - 4
224. NCT00000340Pemoline in the Treatment of Stimulant Dependence - 5
225. NCT00000341Evaluation of Liquid vs. Tablet Buprenorphine - 6
226. NCT00000342Risperidone for the Treatment of Cocaine Dependence - 7
227. NCT00000343Brain Changes in Stimulant Dependent Subjects - 8
228. NCT00000344Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
229. NCT00000345Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
230. NCT00000346Cognitive Correlates of Substance Abuse - 11
231. NCT00000347Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
232. NCT00000348Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
233. NCT00000349Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
234. NCT00000350Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
235. NCT00000351Cognitive Correlates of Substance Abuse, Part 2 - 16
236. NCT00000352Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
237. NCT00000353Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
238. NCT00000354Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
239. NCT00000355Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
240. NCT00000356Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
241. NCT00000357Buprenorphine Maintenance for Opiate Dependence - 6
242. NCT00000358Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
243. NCT00000359Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
244. NCT00000361Autoimmunity in Inner Ear Disease
245. NCT00000362Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term…
246. NCT00000363Acute Otitis Media: Adjuvant Therapy to Improve Outcome
247. NCT00000367Prevention of Suicide in the Elderly
248. NCT00000368Treatment of Panic Disorder: Long Term Strategies
249. NCT00000369Maintenance Therapies in Bipolar Disorders
250. NCT00000370Treatment of Social Phobia
251. NCT00000371Trial of D-Cycloserine in Schizophrenia
252. NCT00000372Glycine and D-Cycloserine in Schizophrenia
253. NCT00000373Treatment of Obsessive-Compulsive Disorder
254. NCT00000374Treatment for First-Episode Schizophrenia
255. NCT00000375Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With…
256. NCT00000376Cognitive and Drug Therapy for Drug-Resistant Depression
257. NCT00000377Preventing the Return of Depression in Elderly Patients
258. NCT00000378Antidepressant Treatment of Melancholia in Late Life
259. NCT00000379Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
260. NCT00000380Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
261. NCT00000381Fluoxetine for Anxious Children
262. NCT00000382Preventing Child Abuse in Infants
263. NCT00000383Treatment of Post-Traumatic Stress Disorder (PTSD) in Sexually Abused Children
264. NCT00000384Treatment of Obsessive-Compulsive Disorder (OCD) in Children
265. NCT00000385Long-Term Lithium Treatment for Aggressive Conduct Disorder
266. NCT00000386Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)
267. NCT00000387Self-Management Therapy for Youth With Schizophrenia
268. NCT00000388Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder…
269. NCT00000389Treatment for Anxiety in Children
270. NCT00000390Antidepressant Treatment of AIDS Related Depression.
271. NCT00000391A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human…
272. NCT00000392Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive…
273. NCT00000393A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired…
274. NCT00000394Acupuncture for Carpal Tunnel Syndrome
275. NCT00000395Antifolate Effectiveness in Arthritis
276. NCT00000396Arthritis Patient Education for Urban African Americans
277. NCT00000397Behavioral Insomnia Therapy for Fibromyalgia
278. NCT00000398Behavioral Treatment of Fibromyalgia
279. NCT00000399Bone Estrogen Strength Training
280. NCT00000400Alendronate and/or Parathyroid Hormone for Osteoporosis
281. NCT00000401Oral Collagen for Rheumatoid Arthritis
282. NCT00000402Calcium and Bone Mass in Young Females
283. NCT00000403Doxycycline and OA Progression
284. NCT00000404Effects of Comprehensive Care for Knee OA
285. NCT00000405Effects of Jumping on Growing Bones
286. NCT00000406Effects of Strength Training on Knee Osteoarthritis
287. NCT00000407Improving Vocational Outcomes in Arthritis
288. NCT00000408Low Back Pain Patient Education Evaluation
289. NCT00000409Spine Patient Outcomes Research Trial (SPORT): Degenerative Spondylolisthesis With Spinal…
290. NCT00000410Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation
291. NCT00000411Spine Patient Outcomes Research Trial (SPORT): Spinal Stenosis
292. NCT00000412Osteoporosis Prevention After Heart Transplant
293. NCT00000413Osteoporosis Prevention in Preadolescent Girls
294. NCT00000414Patient Education in Rheumatoid Arthritis and Osteoarthritis
295. NCT00000415Physical Activity, Calcium, and Bone in Children
296. NCT00000416Prevention of Arthritis-Related Work Disability
297. NCT00000417Psychoeducational Approach to Improve Health in Lupus
298. NCT00000418Psychosocial Treatment for Acute Low Back Pain
299. NCT00000419Safety of Estrogens in Lupus: Hormone Replacement Therapy
300. NCT00000420Safety of Estrogens in Lupus: Birth Control Pills
301. NCT00000421Serologically Active, Clinically Stable Systemic Lupus Erythematosus
302. NCT00000422Tailored Treatments of Fibromyalgia
303. NCT00000423Support, Health, and Fibromyalgia
304. NCT00000424Tidal Lavage in Knee Osteoarthritis
305. NCT00000425Toward Better Outcomes in Osteoarthritis
306. NCT00000426Treatment of Calcium Deficiency in Young Women
307. NCT00000427Effects of Parathyroid Hormone in Men With Osteoporosis
308. NCT00000428Combining N-of-1 Trials to Assess Fibromyalgia Treatments
309. NCT00000429Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
310. NCT00000430Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
311. NCT00000431Preliminary Testing of New Treatment for Chronic Leg Wounds
312. NCT00000432Lyme Disease Prevention Program
313. NCT00000433Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
314. NCT00000434Impact of Exercise on Older Persons With Osteoarthritis
315. NCT00000435dnaJ Peptide for Relieving Rheumatoid Arthritis
316. NCT00000436Improving Functional Recovery After Hip Fracture
317. NCT00000437Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
318. NCT00000438Naltrexone Treatment for Alcoholism
319. NCT00000439Drug Treatment for Alcoholics With Bipolar Disorder
320. NCT00000440Sertraline and Naltrexone for Alcohol Dependence
321. NCT00000441Drug Therapy for Alcohol Detoxification
322. NCT00000442Naltrexone for Relapse Prevention
323. NCT00000443Ondansetron Treatment for Alcoholism
324. NCT00000444Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
325. NCT00000445Use of Naltrexone in a Clinical Setting
326. NCT00000446Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
327. NCT00000447Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
328. NCT00000448Naltrexone Treatment for Alcoholic Women
329. NCT00000449Behavior and Naltrexone Treatment for Alcoholics
330. NCT00000450Naltrexone Maintenance Treatment of Alcoholism
331. NCT00000451Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
332. NCT00000452Naltrexone Treatment of Alcohol Dependence
333. NCT00000454Smoking Cessation in Alcoholism Treatment
334. NCT00000455Naltrexone for Early Problem Drinkers
335. NCT00000456Behavioral Therapy Plus Naltrexone for Alcoholism
336. NCT00000457Pharmacologic Relapse Prevention for Alcoholic Smokers
337. NCT00000458Sertraline and Cognitive Therapy in Depressed Alcoholics
338. NCT00000459Dietary Intervention Study in Children (DISC)
339. NCT00000460Training Levels Comparison Trial
340. NCT00000461Harvard Atherosclerosis Reversibility Project (HARP)
341. NCT00000462Bypass Angioplasty Revascularization Investigation (BARI)
342. NCT00000463Post Coronary Artery Bypass Graft (CABG) Study
343. NCT00000464Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
344. NCT00000465Emory Angioplasty Versus Surgery Trial (EAST)
345. NCT00000466Postmenopausal Estrogen/Progestin Interventions (PEPI)
346. NCT00000467Child and Adolescent Trial for Cardiovascular Health (CATCH)
347. NCT00000468Myocardial Infarction Triage and Intervention Project (MITI)
348. NCT00000469Asymptomatic Carotid Artery Plaque Study (ACAPS)
349. NCT00000470Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest
350. NCT00000471Lifestyle Heart Trial
351. NCT00000472Thrombolysis in Myocardial Ischemia Trial (TIMI III)
352. NCT00000473Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
353. NCT00000474Prevention and Treatment of Hypertension Study (PATHS)
354. NCT00000475Prevention of Early Readmission in Elderly Congestive Heart Failure Patients
355. NCT00000476Digitalis Investigation Group (DIG)
356. NCT00000477Cholesterol Reduction in Seniors Program (CRISP)
357. NCT00000478Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
358. NCT00000479Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the…
359. NCT00000480Multicenter Unsustained Tachycardia Trial (MUSTT)
360. NCT00000481Women's Health Trial: Feasibility Study in Minority Populations
361. NCT00000482Coronary Drug Project
362. NCT00000483Coronary Drug Project Mortality Surveillance
363. NCT00000484Treatment of Hypertension
364. NCT00000485Hypertension Detection and Follow-up Program (HDFP)
365. NCT00000486Unstable Angina Pectoris Trial
366. NCT00000487Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease…
367. NCT00000488Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
368. NCT00000489Coronary Artery Surgery Study (CASS)
369. NCT00000490Program on Surgical Control of Hyperlipidemias (POSCH)
370. NCT00000491Aspirin-Myocardial Infarction Study (AMIS)
371. NCT00000492Beta-Blocker Heart Attack Trial (BHAT)
372. NCT00000493Multicenter Investigation of Limitation of Infarct Size (MILIS)
373. NCT00000494Management of Patent Ductus in Premature Infants
374. NCT00000495Prevention of Hypertension: A Randomized Trial
375. NCT00000496Platelet Drug Trial in Coronary Disease Progression
376. NCT00000497Dietary Intervention Study for Hypertension (DISH)
377. NCT00000498Control of Hypertension by Non-Pharmacologic Means
378. NCT00000499Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
379. NCT00000500Physicians' Health Study
380. NCT00000501Hypertension Prevention Trial (HPT) Feasibility Study
381. NCT00000502Evaluation of SC-V Versus Conventional CPR
382. NCT00000503Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
383. NCT00000504Cardiac Arrhythmia Pilot Study (CAPS)
384. NCT00000505Thrombolysis in Myocardial Infarction (TIMI)
385. NCT00000506Cardiovascular System in Obesity: Effect of Treatment
386. NCT00000507Intravenous Streptokinase in Acute Myocardial Infarction
387. NCT00000508Stanford Coronary Risk Intervention Project (SCRIP)
388. NCT00000509Potassium and Sodium to Control Blood Pressure in Hypertensives
389. NCT00000510Platelet-Inhibitor Drug Trial in Coronary Angioplasty
390. NCT00000511Polyunsaturates and KCL to Control Mild Hypertension
391. NCT00000512Familial Atherosclerosis Treatment Study
392. NCT00000513Trial of Antihypertensive Intervention Management
393. NCT00000514Systolic Hypertension in the Elderly Program (SHEP)
394. NCT00000515Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)
395. NCT00000516Studies of Left Ventricular Dysfunction (SOLVD)
396. NCT00000517Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
397. NCT00000518Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
398. NCT00000519Exercise Training and Plasma Lipoproteins in Man
399. NCT00000520Prevention of Coronary Aneurysms in Kawasaki Syndrome
400. NCT00000521Sodium-Potassium Blood Pressure Trial in Children
401. NCT00000522Treatment of Mild Hypertension Study (TOMHS)
402. NCT00000523Optimal Exercise Regimens for Persons at Increased Risk
403. NCT00000524Myocarditis Treatment Trial
404. NCT00000525Diuretics, Hypertension, and Arrhythmias Clinical Trial
405. NCT00000526Cardiac Arrhythmia Suppression Trial (CAST)
406. NCT00000527Recurrent Carotid Stenosis
407. NCT00000528Trials of Hypertension Prevention (TOHP)
408. NCT00000529Tamoxifen Study
409. NCT00000530Raynaud's Treatment Study (RTS)
410. NCT00000531Antiarrhythmics Versus Implantable Defibrillators (AVID)
411. NCT00000532Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
412. NCT00000533Montreal Heart Attack Readjustment Trial (M-HART)
413. NCT00000534Calcium for Pre-Eclampsia Prevention (CPEP)
414. NCT00000535Trial of Nonpharmacologic Interventions in Elderly (TONE)
415. NCT00000536Sodium Sensitivity in African Americans
416. NCT00000537Stress Reduction & CVD Morbidity and Mortality in Blacks
417. NCT00000538Dietary Effects on Lipoproteins and Thrombogenic Activity
418. NCT00000539Arterial Disease Multifactorial Intervention Trial (ADMIT)
419. NCT00000540Coronary Artery Bypass Graft (CABG) Patch Trial
420. NCT00000541Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
421. NCT00000542Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
422. NCT00000543Oral Calcium in Pregnant Women With Hypertension
423. NCT00000544Dietary Approaches to Stop Hypertension (DASH)
424. NCT00000545PATHWAYS--FULL SCALE STUDY
425. NCT00000546Stress Reduction and Atherosclerotic CVD in Blacks
426. NCT00000547Enalapril After Anthracycline Cardiotoxicity
427. NCT00000548Inhaled NO in Prevention of Chronic Lung Disease
428. NCT00000549Estrogen Replacement and Atherosclerosis (ERA) in Older Women
429. NCT00000550Rapid Early Action for Coronary Treatment (REACT)
430. NCT00000551Activity Counseling Trial (ACT)
431. NCT00000552Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
432. NCT00000553HDL-Atherosclerosis Treatment Study (HATS)
433. NCT00000554Women's Ischemia Syndrome Evaluation (WISE)
434. NCT00000555Women's Angiographic Vitamin and Estrogen Trial (WAVE)
435. NCT00000556Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
436. NCT00000557Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients
437. NCT00000558Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
438. NCT00000559Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial…
439. NCT00000560Beta-Blocker Evaluation in Survival Trial (BEST)
440. NCT00000561Mode Selection Trial in Sinus Node Dysfunction (MOST)
441. NCT00000562Extracorporeal Support for Respiratory Insufficiency (ECMO)
442. NCT00000563Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration
443. NCT00000564Nocturnal Oxygen Therapy
444. NCT00000565Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
445. NCT00000566Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
446. NCT00000567High Frequency Ventilation in Premature Infants (HIFI)
447. NCT00000568Lung Health Study (LHS) I and III
448. NCT00000569Lung Health Study II
449. NCT00000570Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
450. NCT00000571Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease
451. NCT00000572Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome
452. NCT00000573Emphysema: Physiologic Effects of Nutritional Support
453. NCT00000574Ibuprofen in Sepsis Study
454. NCT00000575Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2)…
455. NCT00000576Inhaled Beclomethasone to Prevent Chronic Lung Disease
456. NCT00000577Asthma Clinical Research Network (ACRN)
457. NCT00000578NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
458. NCT00000579Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
459. NCT00000580Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B…
460. NCT00000581Granulocyte Transfusion Study
461. NCT00000582Cooperative Study of Factor VIII Inhibitors
462. NCT00000583Hepatitis B Vaccine Clinical Trial
463. NCT00000584Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
464. NCT00000585Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
465. NCT00000586Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)
466. NCT00000587Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection
467. NCT00000588Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
468. NCT00000589Trial to Reduce Alloimmunization to Platelets (TRAP)
469. NCT00000590Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission…
470. NCT00000591T-Cell Depletion in Unrelated Donor Marrow Transplantation
471. NCT00000592Stroke Prevention in Sickle Cell Anemia (STOP 1)
472. NCT00000593Viral Activation Transfusion Study (VATS)
473. NCT00000594NHLBI Type II Coronary Intervention Study
474. NCT00000595Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
475. NCT00000596Diffuse Fibrotic Lung Disease
476. NCT00000597Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other…
477. NCT00000598Diet and Exercise for Elevated Risk (DEER)
478. NCT00000599Cholesterol-Lowering Atherosclerosis Study (CLAS)
479. NCT00000600Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
480. NCT00000601Postmenopausal Hormone Therapy in Unstable Angina
481. NCT00000602Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)
482. NCT00000603Cord Blood Stem Cell Transplantation Study (COBLT)
483. NCT00000604Influence of CPB Temperature on CABG Morbidity
484. NCT00000605Estrogen and Graft Atherosclerosis Research Trial (EAGER)
485. NCT00000606National Emphysema Treatment Trial (NETT)
486. NCT00000607Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart…
487. NCT00000608Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)
488. NCT00000609Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
489. NCT00000610Magnesium in Coronaries (MAGIC)
490. NCT00000611Women's Health Initiative (WHI)
491. NCT00000612Soy Estrogen Alternative Study (SEA)
492. NCT00000613CVD Risk and Health in Postmenopausal Phytoestrogen Users
493. NCT00000614Prevention of Recurrent Venous Thromboembolism (PREVENT)
494. NCT00000615Girls Health Enrichment Multi-Site Studies (GEMS)
495. NCT00000616PREMIER: Lifestyle Interventions for Blood Pressure Control
496. NCT00000617Azithromycin and Coronary Events Study (ACES)
497. NCT00000619Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization…
498. NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)
499. NCT00000621Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
500. NCT00000623Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
501. NCT00000625A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With…
502. NCT00000626Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated…
503. NCT00000627Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and…
504. NCT00000628A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine
505. NCT00000629The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in…
506. NCT00000630Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine…
507. NCT00000631A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV…
508. NCT00000632A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3…
509. NCT00000633A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of…
510. NCT00000634A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
511. NCT00000635Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With…
512. NCT00000636Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV)…
513. NCT00000637A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI)…
514. NCT00000638Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency…
515. NCT00000639A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to…
516. NCT00000640A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine…
517. NCT00000641A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in…
518. NCT00000642A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G…
519. NCT00000643Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
520. NCT00000644A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M…
521. NCT00000645A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less…
522. NCT00000646Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in…
523. NCT00000647An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With…
524. NCT00000648A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed…
525. NCT00000649An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety…
526. NCT00000650An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in…
527. NCT00000651A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT…
528. NCT00000652A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and…
529. NCT00000653A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With…
530. NCT00000654The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of…
531. NCT00000655A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim)…
532. NCT00000656A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination…
533. NCT00000657Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients…
534. NCT00000658A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With…
535. NCT00000659A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex…
536. NCT00000660Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
537. NCT00000661The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the…
538. NCT00000662A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV…
539. NCT00000663A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G…
540. NCT00000664Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV…
541. NCT00000665Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial…
542. NCT00000666A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic…
543. NCT00000667A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type…
544. NCT00000668A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
545. NCT00000669A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered…
546. NCT00000670Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on…
547. NCT00000671A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine…
548. NCT00000672An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice…
549. NCT00000673A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS…
550. NCT00000674A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic…
551. NCT00000675A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin…
552. NCT00000676Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention…
553. NCT00000677SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed…
554. NCT00000678Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of…
555. NCT00000679(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus…
556. NCT00000680A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused…
557. NCT00000681A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV)…
558. NCT00000682A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status…
559. NCT00000683A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and…
560. NCT00000684Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected…
561. NCT00000685A Study of Zidovudine in HIV-Infected Patients With Kidney Problems
562. NCT00000686A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT
563. NCT00000687Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of…
564. NCT00000688A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral…
565. NCT00000689Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in…
566. NCT00000690Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran…
567. NCT00000691A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS…
568. NCT00000692Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired…
569. NCT00000693Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and…
570. NCT00000694A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor…
571. NCT00000695Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and…
572. NCT00000696A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose…
573. NCT00000697A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients…
574. NCT00000698A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With…
575. NCT00000699A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic…
576. NCT00000700A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human…
577. NCT00000701A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency…
578. NCT00000702A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT)…
579. NCT00000703Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in…
580. NCT00000704A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of…
581. NCT00000705Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia
582. NCT00000706Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine
583. NCT00000707Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing…
584. NCT00000708Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for…
585. NCT00000709An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With…
586. NCT00000710A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI)…
587. NCT00000711Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of…
588. NCT00000712A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and…
589. NCT00000713A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects…
590. NCT00000714An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS…
591. NCT00000715A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral…
592. NCT00000716A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With…
593. NCT00000717The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate…
594. NCT00000718A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and…
595. NCT00000719A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients…
596. NCT00000720A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in…
597. NCT00000721An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody…
598. NCT00000722Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the…
599. NCT00000723The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With…
600. NCT00000724A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to…
601. NCT00000725A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and…
602. NCT00000726Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired…
603. NCT00000727A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized…
604. NCT00000728Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients…
605. NCT00000729A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL…
606. NCT00000730Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients
607. NCT00000731Evaluation of the Interaction Between Acetaminophen and Zidovudine
608. NCT00000732Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and…
609. NCT00000733Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus…
610. NCT00000734Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and…
611. NCT00000735A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of…
612. NCT00000736Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
613. NCT00000737A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate…
614. NCT00000738Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological…
615. NCT00000739Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii…
616. NCT00000740Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected…
617. NCT00000741The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis…
618. NCT00000742A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics…
619. NCT00000743A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
620. NCT00000744A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for…
621. NCT00000745A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the…
622. NCT00000746A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a…
623. NCT00000747An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine…
624. NCT00000748A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole…
625. NCT00000749A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120…
626. NCT00000750A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With…
627. NCT00000751A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum…
628. NCT00000752Preventing Frequent Sinus Infections in HIV-Infected Patients
629. NCT00000753A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT…
630. NCT00000754A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in…
631. NCT00000755A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4…
632. NCT00000756Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded…
633. NCT00000757A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant…
634. NCT00000758A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU)…
635. NCT00000759Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and…
636. NCT00000760A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist)…
637. NCT00000761Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected…
638. NCT00000762A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of…
639. NCT00000763A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
640. NCT00000764Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus…
641. NCT00000765Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline…
642. NCT00000766CMV Retinitis Retreatment Trial
643. NCT00000767A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety…
644. NCT00000768A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With…
645. NCT00000769A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
646. NCT00000770A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded…
647. NCT00000771A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis…
648. NCT00000772A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of…
649. NCT00000773Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone…
650. NCT00000774A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope…
651. NCT00000775A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide…
652. NCT00000776Dexamethasone in Cryptococcal Meningitis
653. NCT00000777Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >=…
654. NCT00000778A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity…
655. NCT00000779A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected…
656. NCT00000780A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
657. NCT00000781A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating…
658. NCT00000782A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV…
659. NCT00000783Heterosexual HIV Transmission Study (HATS)
660. NCT00000784A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant…
661. NCT00000785A Registry of Tuberculosis Cases in the CPCRA
662. NCT00000787Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study
663. NCT00000788A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical…
664. NCT00000789A Randomized, Comparative Trial of Zidovudine (AZT) Versus…
665. NCT00000790Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in…
666. NCT00000791A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine…
667. NCT00000792A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic…
668. NCT00000793A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy…
669. NCT00000794Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus…
670. NCT00000795A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in…
671. NCT00000796A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and…
672. NCT00000797Women's Interagency HIV Study (WIHS)
673. NCT00000798A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN…
674. NCT00000799HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
675. NCT00000800Methadone Effects on Zidovudine (ZDV, AZT) Disposition
676. NCT00000801Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary…
677. NCT00000802A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis…
678. NCT00000803A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With…
679. NCT00000804A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and…
680. NCT00000805A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With…
681. NCT00000806A Phase I Randomized Dose/Formulation Comparison Study of SC-52151
682. NCT00000807Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed…
683. NCT00000808A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant…
684. NCT00000809Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born…
685. NCT00000810Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of…
686. NCT00000811A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in…
687. NCT00000812A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and…
688. NCT00000813A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC…
689. NCT00000814A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With…
690. NCT00000815A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles…
691. NCT00000816Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii…
692. NCT00000817The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo…
693. NCT00000818Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue…
694. NCT00000819A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of…
695. NCT00000820A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With…
696. NCT00000821Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected…
697. NCT00000822A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of…
698. NCT00000823A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among…
699. NCT00000824A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients
700. NCT00000825The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients…
701. NCT00000826Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of…
702. NCT00000827A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected…
703. NCT00000828Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated…
704. NCT00000829A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent…
705. NCT00000830Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord…
706. NCT00000831Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
707. NCT00000832A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial…
708. NCT00000833A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected…
709. NCT00000834A Phase I Study of Methotrexate for HIV Infection
710. NCT00000835A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety…
711. NCT00000836A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)
712. NCT00000837A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
713. NCT00000838Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine…
714. NCT00000839A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women
715. NCT00000840A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on…
716. NCT00000841A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected…
717. NCT00000842A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of…
718. NCT00000843The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children
719. NCT00000844A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three…
720. NCT00000845A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b…
721. NCT00000846A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide…
722. NCT00000847A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205)…
723. NCT00000848The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who…
724. NCT00000849A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children
725. NCT00000850The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV…
726. NCT00000851Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected…
727. NCT00000852A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection
728. NCT00000853A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial…
729. NCT00000854A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight…
730. NCT00000855A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants…
731. NCT00000856A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And…
732. NCT00000857A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With…
733. NCT00000858Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions…
734. NCT00000859A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir…
735. NCT00000860The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of…
736. NCT00000861The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
737. NCT00000862A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
738. NCT00000863A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in…
739. NCT00000864A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With…
740. NCT00000865The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs…
741. NCT00000866A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety…
742. NCT00000867A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS…
743. NCT00000868A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given…
744. NCT00000869A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
745. NCT00000870A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous…
746. NCT00000871A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205…
747. NCT00000872Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With…
748. NCT00000873A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in…
749. NCT00000874A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma…
750. NCT00000875Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following…
751. NCT00000876Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
752. NCT00000877Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an…
753. NCT00000878A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With…
754. NCT00000879A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
755. NCT00000880A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV…
756. NCT00000881A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease
757. NCT00000882Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in…
758. NCT00000883Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected…
759. NCT00000884A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox…
760. NCT00000885Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination…
761. NCT00000886A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide…
762. NCT00000887A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine…
763. NCT00000888Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected…
764. NCT00000889A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to…
765. NCT00000890A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive…
766. NCT00000891Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy…
767. NCT00000892A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used…
768. NCT00000893Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With…
769. NCT00000894Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who…
770. NCT00000895A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With…
771. NCT00000896A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in…
772. NCT00000897A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions…
773. NCT00000898The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir…
774. NCT00000899A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive…
775. NCT00000900The Effects of Illnesses on HIV Levels in the Body
776. NCT00000901Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to…
777. NCT00000902A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children…
778. NCT00000903Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment…
779. NCT00000904Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
780. NCT00000905A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV)…
781. NCT00000906Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients
782. NCT00000907A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated…
783. NCT00000908A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in…
784. NCT00000909A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4…
785. NCT00000910A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
786. NCT00000911A Study to Monitor Patients With Primary or Early HIV Infection
787. NCT00000912A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
788. NCT00000913A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in…
789. NCT00000914A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals…
790. NCT00000915An HIV Vaccine Preparedness Study
791. NCT00000916A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent…
792. NCT00000917Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
793. NCT00000918A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After…
794. NCT00000919A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV…
795. NCT00000920Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to…
796. NCT00000921The Effects of Prednisone on HIV Levels and the Immune System
797. NCT00000922A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV…
798. NCT00000923Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for…
799. NCT00000924A Study to Compare Two Different Anti-HIV Drug Regimens
800. NCT00000925A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable…
801. NCT00000926A Study of Nonoxynol-9 (N-9) and HIV Infection
802. NCT00000927A Study of BufferGel in Women
803. NCT00000928Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples
804. NCT00000929A Study of the Effects of Advantage 24 on the Rectum
805. NCT00000930A Study of HIV in Newly Infected Individuals
806. NCT00000931HIV Prevention Counseling for Men Who Have Sex With Men
807. NCT00000932A Study of the Long-Term Outcomes of HIV-Positive Patients
808. NCT00000933Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A…
809. NCT00000935An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in…
810. NCT00000936A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
811. NCT00000937Study and Treatment of Post Lyme Disease (STOP-LD)
812. NCT00000938A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and…
813. NCT00000939A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels…
814. NCT00000940Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have…
815. NCT00000941A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs…
816. NCT00000942A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
817. NCT00000943A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of…
818. NCT00000944A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy…
819. NCT00000945A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of…
820. NCT00000946A Study to Test the Safety of Three Experimental HIV Vaccines
821. NCT00000947A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive…
822. NCT00000948Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With…
823. NCT00000949A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With…
824. NCT00000950Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
825. NCT00000951A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in…
826. NCT00000952A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
827. NCT00000953Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected…
828. NCT00000954A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
829. NCT00000955Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus…
830. NCT00000956A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant…
831. NCT00000957A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia…
832. NCT00000958A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and…
833. NCT00000959Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV)…
834. NCT00000960The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their…
835. NCT00000961The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG)…
836. NCT00000962The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
837. NCT00000963A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With…
838. NCT00000964The Effect of Stomach Acid on Foscarnet
839. NCT00000965The Effects of Zidovudine on the Blood of HIV-Infected Patients
840. NCT00000966A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in…
841. NCT00000967The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
842. NCT00000968A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of…
843. NCT00000969A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus…
844. NCT00000970A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in…
845. NCT00000971The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the…
846. NCT00000972A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion…
847. NCT00000973A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in…
848. NCT00000974A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis…
849. NCT00000975A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal…
850. NCT00000976A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin…
851. NCT00000977Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1…
852. NCT00000978A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS…
853. NCT00000979Comparison of ddI Versus Zidovudine in HIV-Infected Patients
854. NCT00000980A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
855. NCT00000981The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients…
856. NCT00000982A Study of Azidothymidine in HIV-Infected Children
857. NCT00000983The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
858. NCT00000984A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants…
859. NCT00000985Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients…
860. NCT00000986The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or…
861. NCT00000987A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in…
862. NCT00000988A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex
863. NCT00000989The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With…
864. NCT00000990The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With…
865. NCT00000991A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected…
866. NCT00000992A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in…
867. NCT00000993A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the…
868. NCT00000994A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
869. NCT00000995A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
870. NCT00000996A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
871. NCT00000997A Study of Dideoxycytidine in HIV-Infected Patients
872. NCT00000998A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in…
873. NCT00000999The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in…
874. NCT00001000A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of…
875. NCT00001001A Study of Zidovudine in HIV-Infected Patients With Liver Disease
876. NCT00001002A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken…
877. NCT00001003A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
878. NCT00001004A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related…
879. NCT00001005A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of…
880. NCT00001006A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
881. NCT00001007A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
882. NCT00001008A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex…
883. NCT00001009A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS…
884. NCT00001010A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
885. NCT00001011The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS…
886. NCT00001012A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes
887. NCT00001013Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus…
888. NCT00001014Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the…
889. NCT00001015A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems
890. NCT00001016A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients…
891. NCT00001017Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in…
892. NCT00001018A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
893. NCT00001019Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59…
894. NCT00001020A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy…
895. NCT00001021A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine…
896. NCT00001022A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or…
897. NCT00001023The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin…
898. NCT00001024The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
899. NCT00001025Evaluation of Patients Who Have Not Had Success With Zidovudine
900. NCT00001026A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a…
901. NCT00001027A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in…
902. NCT00001028A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia…
903. NCT00001029A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received…
904. NCT00001030The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination…
905. NCT00001031A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the…
906. NCT00001032A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken…
907. NCT00001033The Treatment of Tuberculosis in HIV-Infected Patients
908. NCT00001034The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of…
909. NCT00001035The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With…
910. NCT00001036The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in…
911. NCT00001037A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of…
912. NCT00001038A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening…
913. NCT00001039Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected…
914. NCT00001040Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro…
915. NCT00001041Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >=…
916. NCT00001042A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the…
917. NCT00001043A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of…
918. NCT00001044A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial…
919. NCT00001045Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms…
920. NCT00001046Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and…
921. NCT00001047Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium…
922. NCT00001048Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to…
923. NCT00001049A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or…
924. NCT00001050Study of Women Who Have AIDS
925. NCT00001052A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial…
926. NCT00001053A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative…
927. NCT00001054The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or…
928. NCT00001055A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205)…
929. NCT00001056A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia…
930. NCT00001057The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients
931. NCT00001058A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of…
932. NCT00001059Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus…
933. NCT00001060A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
934. NCT00001061Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With…
935. NCT00001062A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
936. NCT00001063The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken…
937. NCT00001064A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in…
938. NCT00001065A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in…
939. NCT00001066A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With…
940. NCT00001067The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have…
941. NCT00001068A Study of Disease Progression and Anti-HIV Treatments
942. NCT00001069A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment
943. NCT00001070The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
944. NCT00001071A Study of Stem Cells and Filgrastim
945. NCT00001072A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300…
946. NCT00001073Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical…
947. NCT00001074The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in…
948. NCT00001075The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients
949. NCT00001076A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205)…
950. NCT00001077A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With…
951. NCT00001078A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children…
952. NCT00001079A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in…
953. NCT00001080Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus…
954. NCT00001081A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
955. NCT00001082The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected…
956. NCT00001083Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken…
957. NCT00001084A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in…
958. NCT00001085A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected…
959. NCT00001086A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients
960. NCT00001087The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other…
961. NCT00001088A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine…
962. NCT00001089A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients
963. NCT00001090A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate…
964. NCT00001091Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and…
965. NCT00001092The Biology of HIV Transmission
966. NCT00001093Outcomes of Anti-HIV Therapy During Early HIV Infection
967. NCT00001094A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir…
968. NCT00001095A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
969. NCT00001096A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the…
970. NCT00001097Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker…
971. NCT00001100A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir…
972. NCT00001101A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and…
973. NCT00001102The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients
974. NCT00001103HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs
975. NCT00001104A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia
976. NCT00001105The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
977. NCT00001106A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children
978. NCT00001107Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have…
979. NCT00001108A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4…
980. NCT00001109A Blood Test to Look at Cells of the Immune System in Healthy Children
981. NCT00001110Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell…
982. NCT00001111A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children
983. NCT00001112The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in…
984. NCT00001113A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's…
985. NCT00001114The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With…
986. NCT00001115The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV…
987. NCT00001116A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6)…
988. NCT00001117A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have…
989. NCT00001118Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children
990. NCT00001119Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
991. NCT00001120A Study of Patients With AIDS Syndrome
992. NCT00001121A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
993. NCT00001122A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV…
994. NCT00001123A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a…
995. NCT00001125Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children…
996. NCT00001126Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
997. NCT00001127Study of a Flu Vaccine in Children
998. NCT00001128Treatment of Chronic Cryptosporidiosis in AIDS Patients
999. NCT00001129A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications…
1000. NCT00001130Identifying Emergency Room Patients Who Have Recently Been Infected With HIV